| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 5.1% | -40% | $151,689,488 | -$105,010,859 | 5,772,051 | -41% | FMR LLC | 30 Sep 2025 |
| BlackRock, Inc. | 4.5% | -16% | $140,580,417 | -$23,501,200 | 5,031,511 | -14% | BlackRock, Inc. | 31 Mar 2025 |
As of 31 Dec 2025, 304 institutional investors reported holding 43,868,581 shares of Viking Therapeutics, Inc. - COMMON STOCK (VKTX). This represents 39% of the company’s total 113,177,462 outstanding shares.
The largest institutional shareholders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) together control 33% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 8.8% | 9,984,487 | -0.15% | 0.01% | $351,254,252 |
| BlackRock, Inc. | 5.8% | 6,611,874 | +18% | 0% | $232,605,730 |
| STATE STREET CORP | 3.9% | 4,445,430 | -1.5% | 0.01% | $156,390,227 |
| MORGAN STANLEY | 2.7% | 3,076,270 | -18% | 0.01% | $108,223,187 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 1,994,509 | +24% | 0% | $70,182,515 |
| JANE STREET GROUP, LLC | 1.3% | 1,501,117 | +89% | 0.06% | $52,809,297 |
| BNP PARIBAS FINANCIAL MARKETS | 0.88% | 992,695 | 0% | 0.02% | $34,923,010 |
| UBS Group AG | 0.83% | 934,925 | -30% | 0.01% | $32,890,662 |
| GOLDMAN SACHS GROUP INC | 0.74% | 832,651 | +211% | 0% | $29,292,662 |
| Pictet Asset Management Holding SA | 0.67% | 752,732 | -37% | 0.03% | $26,481,112 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.62% | 700,295 | +0.37% | 0% | $24,636,378 |
| JPMORGAN CHASE & CO | 0.48% | 546,828 | -79% | 0% | $19,237,409 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.46% | 518,796 | -4.7% | 0.05% | $18,251,243 |
| BARCLAYS PLC | 0.46% | 516,656 | +12% | 0.01% | $18,175,958 |
| PRINCIPAL FINANCIAL GROUP INC | 0.45% | 513,731 | -0.05% | 0.01% | $18,073,057 |
| Bank of New York Mellon Corp | 0.42% | 474,621 | -5% | 0% | $16,697,157 |
| DIMENSIONAL FUND ADVISORS LP | 0.41% | 459,575 | -2.5% | 0% | $16,167,849 |
| Clearbridge Investments, LLC | 0.39% | 444,840 | +0.14% | 0.01% | $15,649,471 |
| First Washington CORP | 0.34% | 387,529 | +45% | 3.5% | $13,633,270 |
| STIFEL FINANCIAL CORP | 0.3% | 336,820 | -3.9% | 0.01% | $11,849,350 |
| Steward Partners Investment Advisory, LLC | 0.28% | 316,251 | +2.6% | 0.06% | $11,125,710 |
| AMERICAN CENTURY COMPANIES INC | 0.27% | 305,366 | +3.1% | 0.01% | $10,742,854 |
| WELLS FARGO & COMPANY/MN | 0.25% | 281,264 | -10% | 0% | $9,894,865 |
| Concurrent Investment Advisors, LLC | 0.25% | 281,052 | +1624% | 0.11% | $9,887,409 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.21% | 238,227 | -2.3% | 0% | $8,380,826 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 43,868,581 | $1,543,299,068 | -$53,944,991 | $35.18 | 304 |
| 2025 Q3 | 71,254,905 | $1,872,457,821 | -$130,007,174 | $26.28 | 364 |
| 2025 Q2 | 76,160,666 | $2,018,412,050 | +$15,581,298 | $26.50 | 386 |
| 2025 Q1 | 76,178,049 | $1,840,349,819 | -$233,469,532 | $24.15 | 365 |
| 2024 Q4 | 82,015,393 | $3,300,204,748 | -$139,093,256 | $40.24 | 405 |
| 2024 Q3 | 82,930,091 | $5,250,281,341 | +$233,179,536 | $63.31 | 418 |
| 2024 Q2 | 80,417,324 | $4,262,902,509 | -$169,985,696 | $53.01 | 383 |
| 2024 Q1 | 80,009,652 | $6,559,940,568 | +$370,099,401 | $82.00 | 365 |
| 2023 Q4 | 76,419,206 | $1,422,250,248 | +$18,477,372 | $18.61 | 193 |
| 2023 Q3 | 77,149,919 | $854,043,342 | +$8,950,047 | $11.07 | 176 |
| 2023 Q2 | 74,791,312 | $1,212,232,718 | +$127,119,937 | $16.21 | 192 |
| 2023 Q1 | 66,472,048 | $1,107,025,988 | +$548,273,938 | $16.65 | 183 |
| 2022 Q4 | 34,003,932 | $319,613,212 | +$76,425,883 | $9.40 | 126 |
| 2022 Q3 | 26,578,143 | $72,293,762 | -$1,008,538 | $2.72 | 95 |
| 2022 Q2 | 26,701,115 | $77,182,300 | -$11,574,558 | $2.89 | 97 |
| 2022 Q1 | 31,036,457 | $93,177,398 | -$16,601,086 | $3.00 | 131 |
| 2021 Q4 | 36,199,999 | $166,471,159 | -$8,903,915 | $4.60 | 133 |
| 2021 Q3 | 37,764,404 | $237,662,655 | -$338,194 | $6.28 | 125 |
| 2021 Q2 | 37,867,341 | $226,858,479 | -$19,626,288 | $5.99 | 133 |
| 2021 Q1 | 41,005,365 | $259,319,860 | +$20,962,700 | $6.32 | 137 |
| 2020 Q4 | 37,734,744 | $212,602,882 | -$11,096,629 | $5.63 | 136 |
| 2020 Q3 | 39,564,196 | $230,268,043 | -$4,355,775 | $5.82 | 139 |
| 2020 Q2 | 40,230,477 | $290,007,852 | +$8,150,488 | $7.21 | 133 |
| 2020 Q1 | 39,356,943 | $184,161,493 | -$8,373,431 | $4.68 | 130 |
| 2019 Q4 | 39,771,461 | $318,974,059 | -$5,272,426 | $8.02 | 134 |
| 2019 Q3 | 40,703,230 | $280,039,135 | -$33,395,341 | $6.88 | 139 |
| 2019 Q2 | 45,087,675 | $374,231,879 | -$7,341,449 | $8.30 | 150 |
| 2019 Q1 | 45,718,634 | $454,329,676 | -$4,966,661 | $9.94 | 158 |
| 2018 Q4 | 46,936,233 | $359,030,721 | -$11,223,062 | $7.65 | 159 |
| 2018 Q3 | 43,213,947 | $752,787,195 | +$280,535,030 | $17.42 | 146 |
| 2018 Q2 | 31,601,829 | $299,901,220 | +$126,057,321 | $9.49 | 115 |
| 2018 Q1 | 20,905,622 | $91,354,000 | +$50,569,356 | $4.37 | 62 |
| 2017 Q4 | 9,329,591 | $37,876,000 | +$30,074,098 | $4.06 | 32 |
| 2017 Q3 | 2,021,286 | $3,851,000 | +$1,491,357 | $1.91 | 16 |
| 2017 Q2 | 1,568,425 | $1,692,000 | +$856,257 | $1.08 | 11 |
| 2017 Q1 | 769,601 | $1,124,000 | +$226,915 | $1.46 | 10 |
| 2016 Q4 | 636,030 | $757,000 | -$869,302 | $1.19 | 11 |
| 2016 Q3 | 1,209,905 | $1,701,000 | +$495,636 | $1.41 | 13 |
| 2016 Q2 | 860,090 | $1,083,000 | +$1,026,020 | $1.26 | 12 |
| 2016 Q1 | 44,443 | $65,000 | -$25,998 | $1.53 | 6 |
| 2015 Q4 | 41,278 | $140,000 | -$14,614 | $3.36 | 5 |
| 2015 Q3 | 43,175 | $252,000 | -$77,596 | $5.83 | 6 |
| 2015 Q2 | 54,005 | $384,000 | +$384,000 | $7.10 | 5 |